Home/Hedge Fund Intelligence/Rapport Therapeutics, Inc.
Nasdaq: RAPPStockForm 13F30 Jun 2026

Hedge funds that hold Rapport Therapeutics, Inc. Nasdaq: RAPP

CUSIP 75383L102 · who reports it, how much, and how much it matters to them

18 of the 720 hedge fund managers we track reported shares of Rapport Therapeutics, Inc. (Nasdaq: RAPP) on Form 13F for 30 June 2026. Between them they reported USD 420m. The largest position belongs to Cormorant Asset Management, at USD 111m.

Managers reporting it18of 720 we track
Value they reportUSD 420mshares only, 30 Jun 2026
Funds they run154with a file on PPLI.com
Largest positionUSD 111mCormorant Asset Management
Typical weight0.1%median share of a manager's book
Heaviest weight5.7%Cormorant Asset Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

18 managers, USD 420m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Rapport Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Cormorant Asset Management1 fund on PPLI.comUSD 111m5.7%
2Sofinnova Investments1 fund on PPLI.comUSD 79m4.1%
3Polar Capital LLP26 funds on PPLI.comUSD 67m0.2%
4Baker Bros. Advisors2 funds on PPLI.comUSD 64m0.3%
5Perceptive Advisors6 funds on PPLI.comUSD 32m0.5%
6Sio Capital Management4 funds on PPLI.comUSD 13m2.1%
7Burkehill Global Management5 funds on PPLI.comUSD 10m0.4%
8D. E. Shaw & Co.15 funds on PPLI.comUSD 9m0.0%
9Millennium Management6 funds on PPLI.comUSD 6.5m0.0%
10Adage Capital Management1 fund on PPLI.comUSD 6.3m0.0%
11Artia Global Partners1 fund on PPLI.comUSD 5.8m1.1%
12Walleye Capital8 funds on PPLI.comUSD 4.3m0.0%
13Citadel Advisors32 funds on PPLI.comUSD 3.4m0.0%
14Orbimed Advisors1 fund on PPLI.comUSD 3.2m0.1%
15Dafna Capital Management6 funds on PPLI.comUSD 3.1m0.6%
16Two Sigma Investments35 funds on PPLI.comUSD 1m0.0%
17Engineers Gate Manager1 fund on PPLI.comUSD 888,0000.0%
18Aquatic Capital Management3 funds on PPLI.comUSD 88,0070.0%
Next: where it matters most
Where it matters most

For Cormorant Asset Management it is 5.7% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Cormorant Asset ManagementUSD 111m5.7%
2Sofinnova InvestmentsUSD 79m4.1%
3Sio Capital ManagementUSD 13m2.1%
4Artia Global PartnersUSD 5.8m1.1%
5Dafna Capital ManagementUSD 3.1m0.6%
6Perceptive AdvisorsUSD 32m0.5%
7Burkehill Global ManagementUSD 10m0.4%
8Baker Bros. AdvisorsUSD 64m0.3%
9Polar Capital LLPUSD 67m0.2%
10Orbimed AdvisorsUSD 3.2m0.1%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Rapport Therapeutics, Inc.

What is the ticker symbol of Rapport Therapeutics, Inc.?

Rapport Therapeutics, Inc. trades under the symbol RAPP on the Nasdaq. Its CUSIP, the code used on Form 13F, is 75383L102.

Which hedge funds own Rapport Therapeutics, Inc. (Nasdaq: RAPP)?

18 of the 720 hedge fund managers PPLI.com tracks reported Rapport Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Cormorant Asset Management (USD 111m), Sofinnova Investments (USD 79m), Polar Capital LLP (USD 67m), Baker Bros. Advisors (USD 64m) and Perceptive Advisors (USD 32m).

How many hedge funds hold Rapport Therapeutics, Inc.?

18 managers in our coverage reported it, and between them they run 154 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Rapport Therapeutics, Inc.?

Cormorant Asset Management, where the position was 5.7% of the reported 13F book at 30 June 2026.

Does this show who is short Rapport Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Rapport Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.